{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:53:38Z","timestamp":1758970418026},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1007\/s11920-004-0077-x","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T12:17:25Z","timestamp":1180786645000},"page":"274-279","source":"Crossref","is-referenced-by-count":15,"title":["The molecular neuroimaging of anxiety disorders"],"prefix":"10.1007","volume":"6","author":[{"given":"Peter S.","family":"Talbot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"77_CR1","first-page":"289","volume-title":"Handbook of Depression and Anxiety","author":"PS Talbot","year":"2003","unstructured":"Talbot PS, Mathew SJ, Laruelle M: Brain imaging in depression and anxiety. In Handbook of Depression and Anxiety, edn 2. Edited by Kasper S, den Boer JA, Sitsen JM. New York: Marcel Dekker, Inc.; 2003:289\u2013329.","edition":"edn 2"},{"key":"77_CR2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1192\/bjp.166.2.244","volume":"166","author":"D Perani","year":"1995","unstructured":"Perani D, Colombo C, Bressi S, et al.: [18F]FDG PET study in obsessive-compulsive disorder: a clinical\/metabolic correlation study after treatment. Br J Psychiatry 1995, 166:244\u2013250.","journal-title":"Br J Psychiatry"},{"key":"77_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0893-133X(89)90003-1","volume":"2","author":"TE Nordahl","year":"1989","unstructured":"Nordahl TE, Benkelfat C, Semple WE, et al.: Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology 1989, 2:23\u201328.","journal-title":"Neuropsychopharmacology"},{"key":"77_CR4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.1989.01810060038007","volume":"46","author":"SE Swedo","year":"1989","unstructured":"Swedo SE, Schapiro MB, Grady CL, et al.: Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989, 46:518\u2013523.","journal-title":"Arch Gen Psychiatry"},{"key":"77_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archpsyc.1987.01800150017003","volume":"44","author":"LR Baxter Jr.","year":"1987","unstructured":"Baxter LR Jr., Phelps ME, Mazziotta JC, et al.: Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987, 44:211\u2013218.","journal-title":"Arch Gen Psychiatry"},{"key":"77_CR6","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1176\/ajp.145.12.1560","volume":"145","author":"LR Baxter Jr.","year":"1988","unstructured":"Baxter LR Jr., Schwartz JM, Mazziotta JC, et al.: Cerebral glucose metabolic rates in nondepressed patients with obsessivecompulsive disorder. Am J Psychiatry 1988, 145:1560\u20131563.","journal-title":"Am J Psychiatry"},{"key":"77_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0022-3956(00)00022-4","volume":"34","author":"CM Adler","year":"2000","unstructured":"Adler CM, McDonough-Ryan P, Sax KW, et al.: fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. J Psychiatr Res 2000, 34:317\u2013324.","journal-title":"J Psychiatr Res"},{"key":"77_CR8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1192\/bjp.164.4.459","volume":"164","author":"PK McGuire","year":"1994","unstructured":"McGuire PK, Bench CJ, Frith CD, et al.: Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 1994, 164:459\u2013468.","journal-title":"Br J Psychiatry"},{"key":"77_CR9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archpsyc.1996.01830070041008","volume":"53","author":"HC Breiter","year":"1996","unstructured":"Breiter HC, Rauch SL, Kwong KK, et al.: Functional magnetic resonance imaging of symptom provocation in obsessivecompulsive disorder. Arch Gen Psychiatry 1996, 53:595\u2013606.","journal-title":"Arch Gen Psychiatry"},{"key":"77_CR10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1994.03950010062008","volume":"51","author":"SL Rauch","year":"1994","unstructured":"Rauch SL, Jenike MA, Alpert NM, et al.: Regional cerebral blood flow measured during symptom provocation in obsessivecompulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994, 51:62\u201370.","journal-title":"Arch Gen Psychiatry"},{"key":"77_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0006-3223(98)00099-7","volume":"45","author":"J Pujol","year":"1999","unstructured":"Pujol J, Torres L, Deus J, et al.: Functional magnetic resonance imaging study of frontal lobe activation during word generation in obsessive-compulsive disorder. Biol Psychiatry 1999, 45:891\u2013897.","journal-title":"Biol Psychiatry"},{"key":"77_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0893-133X(99)00082-2","volume":"21","author":"S Saxena","year":"1999","unstructured":"Saxena S, Brody AL, Maidment KM, et al.: Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 1999, 21:683\u2013693.","journal-title":"Neuropsychopharmacology"},{"key":"77_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0925-4927(98)00041-9","volume":"84","author":"AL Brody","year":"1998","unstructured":"Brody AL, Saxena S, Schwartz JM, et al.: FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res 1998, 84:1\u20136.","journal-title":"Psychiatry Res"},{"key":"77_CR14","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1176\/ajp.155.11.1584","volume":"155","author":"R Bartha","year":"1998","unstructured":"Bartha R, Stein MB, Williamson PC, et al.: A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 1998, 155:1584\u20131591.","journal-title":"Am J Psychiatry"},{"key":"77_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0925-4927(97)00016-4","volume":"74","author":"D Ebert","year":"1997","unstructured":"Ebert D, Speck O, Konig A, et al.: 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res 1997, 74:173\u2013176.","journal-title":"Psychiatry Res"},{"key":"77_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0006-3223(99)00286-3","volume":"47","author":"KD Fitzgerald","year":"2000","unstructured":"Fitzgerald KD, Moore GJ, Paulson LA, et al.: Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessivecompulsive disorder. Biol Psychiatry 2000, 47:174\u2013182.","journal-title":"Biol Psychiatry"},{"key":"77_CR17","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0006-3223(03)00474-8","volume":"54","author":"EA Smith","year":"2003","unstructured":"Smith EA, Russell A, Lorch E, et al.: Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biol Psychiatry 2003, 54:1399\u20131405.","journal-title":"Biol Psychiatry"},{"key":"77_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0925-4927(02)00104-X","volume":"122","author":"JS Kwon","year":"2003","unstructured":"Kwon JS, Kim JJ, Lee DW, et al.: Neural correlates of clinical symptoms and cognitive dysfunctions in obsessivecompulsive disorder. Psychiatry Res 2003, 122:37\u201347.","journal-title":"Psychiatry Res"},{"key":"77_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1176\/appi.ajp.160.3.522","volume":"160","author":"S Saxena","year":"2003","unstructured":"Saxena S, Brody AL, Ho ML, et al.: Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry 2003, 160:522\u2013532. This study demonstrates that OCD and MDD have different neurobiologic substrates for response to the same SSRI treatment.","journal-title":"Am J Psychiatry"},{"key":"77_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/archpsyc.59.3.250","volume":"59","author":"S Saxena","year":"2002","unstructured":"Saxena S, Brody AL, Ho ML, et al.: Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 2002, 59:250\u2013261.","journal-title":"Arch Gen Psychiatry"},{"key":"77_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1461145701002681","volume":"5","author":"ES Hansen","year":"2002","unstructured":"Hansen ES, Hasselbalch S, Law I, Bolwig TG: The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int J Neuropsychopharmacol 2002, 5:1\u201310.","journal-title":"Int J Neuropsychopharmacol"},{"key":"77_CR22","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","volume":"39","author":"DR Rosenberg","year":"2000","unstructured":"Rosenberg DR, MacMaster FP, Keshavan MS, et al.: Decrease in caudate glutamatergic concentrations in pediatric obsessivecompulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000, 39:1096\u20131103.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"77_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/00004583-199806000-00017","volume":"37","author":"GJ Moore","year":"1998","unstructured":"Moore GJ, MacMaster FP, Stewart C, Rosenberg DR: Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998, 37:663\u2013667.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"77_CR24","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/00004583-200108000-00011","volume":"40","author":"J Bolton","year":"2001","unstructured":"Bolton J, Moore GJ, MacMillan S, et al.: Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD. J Am Acad Child Adolesc Psychiatry 2001, 40:903\u2013906.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"77_CR25","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/01.chi.0000087562.01900.de","volume":"42","author":"NR Benazon","year":"2003","unstructured":"Benazon NR, Moore GJ, Rosenberg DR: Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy. J Am Acad Child Adolesc Psychiatry 2003, 42:1279\u20131285.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"77_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1034\/j.1600-0447.2003.00070.x","volume":"107","author":"DH Kang","year":"2003","unstructured":"Kang DH, Kwon JS, Kim JJ, et al.: Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 2003, 107:291\u2013297.","journal-title":"Acta Psychiatr Scand"},{"key":"77_CR27","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0006-3223(03)00183-5","volume":"54","author":"O Pogarell","year":"2003","unstructured":"Pogarell O, Hamann C, Popperl G, et al.: Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry 2003, 54:1406\u20131413. This [123I]\u03b2-CIT SPECT study is one of the first two studies reporting on SERT density in OCD. It finds increased SERT, but has a number of limitations and requires replication.","journal-title":"Biol Psychiatry"},{"key":"77_CR28","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/S0006-3223(03)00544-4","volume":"54","author":"HB Simpson","year":"2003","unstructured":"Simpson HB, Lombardo I, Slifstein M, et al.: Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652. Biol Psychiatry 2003, 54:1414\u20131421. In contrast to the study by Pogarell et al. [27], this well-conducted PET study finds no change in SERT density in OCD. However, better PET SERT tracers than [11C]McN5652 now exist, and the results of replication studies will be of interest.","journal-title":"Biol Psychiatry"},{"key":"77_CR29","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1021\/jm000079i","volume":"43","author":"AA Wilson","year":"2000","unstructured":"Wilson AA, Ginovart N, Schmidt M, et al.: Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines. J Med Chem 2000, 43:3103\u20133110.","journal-title":"J Med Chem"},{"key":"77_CR30","first-page":"682","volume":"45","author":"WG Frankle","year":"2004","unstructured":"Frankle WG, Huang Y, Hwang D-R, et al.: Comparative evaluation of serotonin transporter radioligands [11C]DASB and [11C]McN 5652 in healthy humans. J Nucl Med 2004, 45:682\u2013694.","journal-title":"J Nucl Med"},{"key":"77_CR31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1097\/00004647-200211000-00011","volume":"22","author":"Y Huang","year":"2002","unstructured":"Huang Y, Hwang DR, Narendran R, et al.: Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM. J Cereb Blood Flow Metab 2002, 22:1377\u20131398.","journal-title":"J Cereb Blood Flow Metab"},{"key":"77_CR32","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/ajp.155.9.1178","volume":"155","author":"A Bisaga","year":"1998","unstructured":"Bisaga A, Katz J, Antonini A, et al.: Cerebral glucose metabolism in women with panic disorder. Am J Psychiatry 1998, 155:1178\u20131183.","journal-title":"Am J Psychiatry"},{"key":"77_CR33","first-page":"261","volume":"3","author":"TE Nordahl","year":"1990","unstructured":"Nordahl TE, Semple WE, Gross M, et al.: Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology 1990, 3:261\u2013272.","journal-title":"Neuropsychopharmacology"},{"key":"77_CR34","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0006-3223(98)00026-2","volume":"44","author":"TE Nordahl","year":"1998","unstructured":"Nordahl TE, Stein MB, Benkelfat C, et al.: Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders. Biol Psychiatry 1998, 44:998\u20131006.","journal-title":"Biol Psychiatry"},{"key":"77_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0006-3223(93)90004-W","volume":"33","author":"MT De Cristofaro","year":"1993","unstructured":"De Cristofaro MT, Sessarego A, Pupi A, et al.: Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study. Biol Psychiatry 1993, 33:505\u2013512.","journal-title":"Biol Psychiatry"},{"key":"77_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archpsyc.55.8.715","volume":"55","author":"AL Malizia","year":"1998","unstructured":"Malizia AL, Cunningham VJ, Bell CJ, et al.: Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 1998, 55:715\u2013720.","journal-title":"Arch Gen Psychiatry"},{"key":"77_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00006231-199504000-00159","volume":"16","author":"J Kuikka","year":"1995","unstructured":"Kuikka J, Pitkanen A, Lepola U, et al.: Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder. Nucl Med Commun 1995, 16:273\u2013280.","journal-title":"Nucl Med Commun"},{"key":"77_CR38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0022-3956(95)00019-2","volume":"29","author":"W Kaschka","year":"1995","unstructured":"Kaschka W, Feistel H, Ebert D: Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT. J Psychiatr Res 1995, 29:427\u2013434.","journal-title":"J Psychiatr Res"},{"key":"77_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0006-3223(99)00188-2","volume":"47","author":"JD Bremner","year":"2000","unstructured":"Bremner JD, Innis RB, White T, et al.: SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 2000, 47:96\u2013106.","journal-title":"Biol Psychiatry"},{"key":"77_CR40","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s007020050134","volume":"105","author":"CA Brandt","year":"1998","unstructured":"Brandt CA, Meller J, Keweloh L, et al.: Increased benzodiazepine receptor density in the prefrontal cortex in patients with panic disorder. J Neural Transm 1998, 105:1325\u20131333.","journal-title":"J Neural Transm"},{"key":"77_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/archpsyc.58.6.556","volume":"58","author":"AW Goddard","year":"2001","unstructured":"Goddard AW, Mason GF, Almai A, et al.: Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry 2001, 58:556\u2013561.","journal-title":"Arch Gen Psychiatry"},{"key":"77_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0925-4927(97)00066-8","volume":"76","author":"SR Dager","year":"1997","unstructured":"Dager SR, Richards T, Strauss W, Artru A: Single-voxel 1H-MRS investigation of brain metabolic changes during lactateinduced panic. Psychiatry Res 1997, 76:89\u201399.","journal-title":"Psychiatry Res"},{"key":"77_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/archpsyc.56.1.70","volume":"56","author":"SR Dager","year":"1999","unstructured":"Dager SR, Friedman SD, Heide A, et al.: Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. Arch Gen Psychiatry 1999, 56:70\u201377.","journal-title":"Arch Gen Psychiatry"},{"key":"77_CR44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1176\/ajp.151.1.57","volume":"151","author":"SR Dager","year":"1994","unstructured":"Dager SR, Marro KI, Richards TL, Metzger GD: Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic. Am J Psychiatry 1994, 151:57\u201363.","journal-title":"Am J Psychiatry"},{"key":"77_CR45","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1176\/ajp.152.5.666","volume":"152","author":"SR Dager","year":"1995","unstructured":"Dager SR, Strauss WL, Marro KI, et al.: Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am J Psychiatry 1995, 152:666\u2013672.","journal-title":"Am J Psychiatry"},{"key":"77_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1523\/JNEUROSCI.4921-03.2004","volume":"24","author":"A Neumeister","year":"2004","unstructured":"Neumeister A, Bain E, Nugent AC, et al.: Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 2004, 24:589\u2013591. A well-conducted neuroreceptor PET study showing, for the fisrt time, significantly reduced 5-HT1A receptor binding in panic disorder.","journal-title":"J Neurosci"},{"key":"77_CR47","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1176\/appi.ajp.158.8.1326","volume":"158","author":"J Tauscher","year":"2001","unstructured":"Tauscher J, Bagby RM, Javanmard M, et al.: Inverse relationship between serotonin 5-HT1A receptor binding and anxiety: A [11C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry 2001, 158:1326\u20131328.","journal-title":"Am J Psychiatry"},{"key":"77_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1034\/j.1600-0447.2001.00090.x","volume":"103","author":"KM Dewar","year":"2001","unstructured":"Dewar KM, Stravynski A: The quest for biological correlates of social phobia: an interim assessment. Acta Psychiatr Scand 2001, 103:244\u2013251.","journal-title":"Acta Psychiatr Scand"},{"key":"77_CR49","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1176\/appi.ajp.158.10.1558","volume":"158","author":"SJ Mathew","year":"2001","unstructured":"Mathew SJ, Coplan JD, Gorman JM: Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry 2001, 158:1558\u20131567.","journal-title":"Am J Psychiatry"},{"key":"77_CR50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1176\/ajp.154.12.1711","volume":"154","author":"J Tiihonen","year":"1997","unstructured":"Tiihonen J, Kuikka J, Bergstrom K, et al.: Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 1997, 154:239\u2013242.","journal-title":"Am J Psychiatry"},{"key":"77_CR51","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1176\/appi.ajp.157.3.457","volume":"157","author":"FR Schneier","year":"2000","unstructured":"Schneier FR, Liebowitz MR, Abi-Dargham A, et al.: Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 2000, 157:457\u2013459.","journal-title":"Am J Psychiatry"},{"key":"77_CR52","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1176\/ajp.155.10.1440","volume":"155","author":"A Breier","year":"1998","unstructured":"Breier A, Kestler L, Adler C, et al.: Dopamine D2 receptor density and personal detachment in healthy subjects. Am J Psychiatry 1998, 155:1440\u20131442.","journal-title":"Am J Psychiatry"},{"key":"77_CR53","first-page":"48","volume":"13","author":"LP Kestler","year":"2000","unstructured":"Kestler LP, Malhotra AK, Finch C, et al.: The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO Personality Inventory-Revised. Neuropsychiatry Neuropsychol Behav Neurol 2000, 13:48\u201352.","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"77_CR54","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1176\/appi.ajp.157.2.290","volume":"157","author":"A Laakso","year":"2000","unstructured":"Laakso A, Vilkman H, Kajander J, et al.: Prediction of detached personality in healthy subjects by low dopamine transporter binding. Am J Psychiatry 2000, 157:290\u2013292.","journal-title":"Am J Psychiatry"},{"key":"77_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1176\/appi.ajp.158.2.327-a","volume":"158","author":"FR Schneier","year":"2001","unstructured":"Schneier FR, Liebowitz MR, Laruelle M: Detachment and generalized social phobia. Am J Psychiatry 2001, 158:327.","journal-title":"Am J Psychiatry"},{"key":"77_CR56","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1176\/appi.ajp.160.5.904","volume":"160","author":"A Laakso","year":"2003","unstructured":"Laakso A, Wallius E, Kajander J, et al.: Personality traits and striatal dopamine synthesis capacity in healthy subjects. Am J Psychiatry 2003, 160:904\u2013910.","journal-title":"Am J Psychiatry"},{"key":"77_CR57","first-page":"200P","volume":"41","author":"J Kent","year":"2000","unstructured":"Kent J, Coplan JD, Lombardo I, et al.: Imaging the serotonin transporter in social phobia with (+)[C-11]McN5652. J Nucl Med 2000, 41:200P.","journal-title":"J Nucl Med"},{"key":"77_CR58","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00213-002-1218-8","volume":"164","author":"JM Kent","year":"2002","unstructured":"Kent JM, Coplan JD, Lombardo I, et al.: Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652. Psychopharmacology (Berl) 2002, 164:341\u2013348.","journal-title":"Psychopharmacology (Berl)"},{"key":"77_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1053\/scnp.2001.21840","volume":"6","author":"G Villarreal","year":"2001","unstructured":"Villarreal G, King CY: Brain imaging in posttraumatic stress disorder. Semin Clin Neuropsychiatry 2001, 6:131\u2013145.","journal-title":"Semin Clin Neuropsychiatry"},{"key":"77_CR60","first-page":"47","volume":"62","author":"RK Pitman","year":"2001","unstructured":"Pitman RK, Shin LM, Rauch SL: Investigating the pathogenesis of posttraumatic stress disorder with neuroimaging. J Clin Psychiatry 2001, 62:47\u201354.","journal-title":"J Clin Psychiatry"},{"key":"77_CR61","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/archpsyc.57.10.925","volume":"57","author":"RM Sapolsky","year":"2000","unstructured":"Sapolsky RM: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000, 57:925\u2013935.","journal-title":"Arch Gen Psychiatry"},{"key":"77_CR62","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1176\/appi.ajp.157.7.1175","volume":"157","author":"MD De Bellis","year":"2000","unstructured":"De Bellis MD, Keshavan MS, Spencer S, Hall J: N-acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD. Am J Psychiatry 2000, 157:1175\u20131177.","journal-title":"Am J Psychiatry"},{"key":"77_CR63","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1749-6632.1997.tb48319.x","volume":"821","author":"N Schuff","year":"1997","unstructured":"Schuff N, Marmar CR, Weiss DS, et al.: Reduced hippocampal volume and N-acetyl aspartate in posttraumatic stress disorder. Ann N Y Acad Sci 1997, 821:516\u2013520.","journal-title":"Ann N Y Acad Sci"},{"key":"77_CR64","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S0006-3223(01)01245-8","volume":"50","author":"N Schuff","year":"2001","unstructured":"Schuff N, Neylan TC, Lenoci MA, et al.: Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry 2001, 50:952\u2013959.","journal-title":"Biol Psychiatry"},{"key":"77_CR65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/mrm.1910400110","volume":"40","author":"TW Freeman","year":"1998","unstructured":"Freeman TW, Cardwell D, Karson CN, Komoroski RA: In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn Reson Med 1998, 40:66\u201371.","journal-title":"Magn Reson Med"},{"key":"77_CR66","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1176\/jnp.15.3.367","volume":"15","author":"S Brown","year":"2003","unstructured":"Brown S, Freeman T, Kimbrell T, et al.: In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of former prisoners of war with and without posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci 2003, 15:367\u2013370.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"77_CR67","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/070674370204700709","volume":"47","author":"G Villarreal","year":"2002","unstructured":"Villarreal G, Petropoulos H, Hamilton DA, et al.: Proton magnetic resonance spectroscopy of the hippocampus and occipital white matter in PTSD: preliminary results. Can J Psychiatry 2002, 47:666\u2013670.","journal-title":"Can J Psychiatry"},{"key":"77_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3348\/kjr.2003.4.2.79","volume":"4","author":"MK Lim","year":"2003","unstructured":"Lim MK, Suh CH, Kim HJ, et al.: Fire-related post-traumatic stress disorder: brain 1H-MR spectroscopic findings. Korean J Radiol 2003, 4:79\u201384.","journal-title":"Korean J Radiol"},{"key":"77_CR69","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S0006-3223(02)01974-1","volume":"54","author":"TC Neylan","year":"2003","unstructured":"Neylan TC, Schuff N, Lenoci M, et al.: Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol Psychiatry 2003, 54:1118\u20131121.","journal-title":"Biol Psychiatry"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0077-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-004-0077-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0077-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0077-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T10:10:17Z","timestamp":1652609417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-004-0077-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["77"],"URL":"https:\/\/doi.org\/10.1007\/s11920-004-0077-x","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}